Contact Us


UK Early Detection Initiative for Pancreatic Cancer

UK-EDI is a research programme funded by Cancer Research UK which will explore the link between new-onset diabetes and pancreatic cancer with the aim of finding ways to diagnose pancreatic cancer earlier.

Most cases of type 2 diabetes are due to lifestyle or genetic factors. However, in approximately 1% of people, a new diagnosis of type 2 diabetes could be an early warning sign of pancreatic cancer.

Through this research we hope to develop a diagnostic test for use in individuals newly diagnosed with diabetes which will identify those most at risk of pancreatic cancer, allowing them to be screened.

The aim of UK-EDI is to detect pancreatic cancer earlier.

UK-EDI consists of seven work packages that contribute to the overall aim of the programme.

UK-EDI is hosted by the University of Liverpool in collaboration with the Liverpool Clinical Trials Centre (LCTC), Liverpool GCP labs, Liverpool ECMC (Liverpool PHPB centre) and the University of Strathclyde.










If you are interested in finding out how we handle your personal data please visit this site












Lost Username / Password?